|
 |
| ORIGINAL ARTICLE |
|
| Year : 2021 | Volume
: 22
| Issue : 4 | Page : 240-248 |
|
|
Precipitating factors leading to hospitalization and mortality in heart failure patients: Findings from gulf CARE
Abdulla Shehab1, Kadhim Sulaiman2, Feras Barder3, Haitham Amin4, Amar M Salam5
1 Department of Interventional Cardiology, Al Ain Hospital, Al Ain, United Arab Emirates
2 National Heart Center, Royal Hospital, Muscat, Oman
3 Cleveland Clinic Abu Dhabi, Heart and Vascular Institute, Al Maryah Island, Abu Dhabi, United Arab Emirates
4 Department of Cardiology, Mohammed Bin Khalifa Cardiac Centre, Awali, Bahrain
5 Department of Cardiology, College of Medicine, Qatar University, Doha, Qatar
| Date of Submission | 25-Feb-2021 |
| Date of Decision | 23-Jun-2021 |
| Date of Acceptance | 13-Dec-2021 |
| Date of Web Publication | 11-Feb-2022 |
Correspondence Address:
Prof. Abdulla Shehab
Department of Interventional Cardiology, Al Ain Hospital, Al Ain
United Arab Emirates
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_32_21
 Abstract | | |
Aim: To investigate the precipitating factors that contribute to hospitalization and mortality in postacute heart failure (AHF) hospitalization in the Middle-East region.
Methods: We evaluated patient data from the Gulf AHF registry (Gulf CARE), a prospective multicenter study conducted on hospitalized AHF patients in 47 hospitals across seven Middle Eastern Gulf countries in 2012. We performed analysis by adjusting confounders to identify important precipitating factors contributing to rehospitalization and 90- to 120-day follow-up mortality.
Results: The mean age of the cohort (n = 5005) was 59.3 ± 14.9 years. Acute coronary syndrome (ACS) (27.2%), nonadherence to diet (19.2%), and infection (14.6%) were the most common precipitating factors identified. After adjusting for confounders, patients with AHF precipitated by infection (hazard ratio [HR], 1.40; 95% confidence interval [CI] 1.10–1.78) and ACS (HR-1.23; 95% CI: 0.99-1.52) at admission showed a higher 90-day mortality. Similarly, AHF precipitated by infection (HR-1.13; 95% CI: 0.93–1.37), and nonadherence to diet and medication (HR-1.12; 95% CI: 0.94–1.34) during hospitalization showed a persistently higher risk of 12-month mortality compared with AHF patients without identified precipitants.
Conclusion: Precipitating factors such as ACS, nonadherence to diet, and medication were frequently identified as factors that influenced frequent hospitalization and mortality. Hence, early detection, management, and monitoring of these prognostic factors in-hospital and postdischarge should be prioritized in optimizing the management of HF in the Gulf region.
Keywords: Acute heart failure, Gulf acute heart failure registry (Gulf CARE), mortality, precipitating factors, readmission, risk factors
How to cite this article:
Shehab A, Sulaiman K, Barder F, Amin H, Salam AM. Precipitating factors leading to hospitalization and mortality in heart failure patients: Findings from gulf CARE. Heart Views 2021;22:240-8 |
How to cite this URL:
Shehab A, Sulaiman K, Barder F, Amin H, Salam AM. Precipitating factors leading to hospitalization and mortality in heart failure patients: Findings from gulf CARE. Heart Views [serial online] 2021 [cited 2023 Mar 23];22:240-8. Available from: https://www.heartviews.org/text.asp?2021/22/4/240/337543 |
| Introduction | |  |
Precipitating factors contributing to exacerbations of heart failure (HF) are associated with substantial morbidity and mortality. Understanding precipitants that contribute to rehospitalization and mortality is important and could have a positive influence on HF disease management. The Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) registry has identified ischemia and worsening renal function as precipitating factors for rehospitalization associated with increased risk of 60- to 90-day mortality after discharge.[1] However, to change the outcomes post-HF hospitalization, more research is needed for the early recognition of precipitating factors for rehospitalization and mortality. Identifying patients at early stages of HF would allow the implementation of more aggressive risk management strategies and should also decrease the progression to symptomatic disease. Several large registries such as Acute Decompensated Heart Failure National Registry, OPTIMIZE-HF, the American Heart Association's ongoing Get with the Guidelines – heart failure (GWTG-HF) registry and the most recent European Society of Cardiology Heart Failure Long-Term Registry demonstrated the clinical profiles and outcomes of HF patients from Western countries.[2],[3],[4],[5] All these registries helped the American and European cardiovascular communities frame competent HF guidelines. The GWTG-HF registry data reported the extent of inappropriate or underuse of medications or device therapy in patients with HF.[4]
The few available systematic data from Middle East countries suggest that the burden of patients with HF may be higher than that in Western countries.[6],[7],[8] However, variations in risk factors in patients with acute HF (AHF) in the Middle East populations remain unclear.
The Gulf Heart Association (GHA) initiated the first prospective, multinational, multicenter observational AHF registry (Gulf CARE) involving seven Middle East countries, including Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, the United Arab Emirates, and Yemen between February and November of 2012. Through this study, we aimed to investigate precipitating factors that contribute to hospitalization and mortality in post-AHF hospitalization in a large Gulf CARE cohort.
| Methods | | |
Registry design
Gulf CARE registry design, methodology, and hospital characteristics have been previously described in detail.[9] Hospital-based registry patients admitted with AHF in participating hospitals in the 47 selected hospitals across seven Middle East regions were included.
Baseline demographics, comorbidities, risk factors, clinical presentations, in-hospital outcomes, management strategies, etiology, precipitating factors for worsening of HF (have persistent symptoms and signs of HF during treatment or pulmonary edema, or cardiogenic shock after stabilization and treatment of at least 24 h any of which requires rehospitalization) and other relevant data collected during admission and on follow-up were obtained from the Gulf CARE data using predefined inclusion and exclusion criteria.[9]
The registered patients were followed for 3 months to 1 year. To better understand the precipitating factors among Gulf population, we stratified the Gulf CARE registries into two groups based on their nationalities: Arab Gulf Corporation Council (GCC) that includes the United Arab Emirates, Bahrain, Saudi Arabia, Oman, Qatar and Kuwait, and nonGCC (Yemen and others). Six distinct classes of precipitating factors (acute coronary syndrome [ACS], nonadherence to medications, infection, uncontrolled arrhythmias, uncontrolled hypertension, and non-adherence to diet) for hospital admission were considered. Patients with these precipitating factors and the outcomes of the 90-day and 120-day all-cause mortality were investigated across the Gulf CARE cohort.
Ethical considerations
Institutional or national ethical committee or review board approval was obtained from 47 sites of the seven participating countries. The study protocol was registered at clinicaltrials.gov (NCT01467973). We strictly followed the 1975 Declaration of Helsinki's ethical guidelines. Written informed consent was obtained from each patient before their enrollment in the study. We used a custom-designed electronic case report form and entered the data online at the Gulf CARE website (www.gulfcare.org). Data characteristics and outcome variables were similar to that of previously published Gulf CARE studies.[10],[11],[12],[13],[14],[15],[16]
Patient and public involvement
Each patient who participated in the study was given a unique identification number. All the necessary information related to the research hypothesis, patient enrollment, and outcome measures were described in the study protocol.[9] The study was registered with clinical trials.gov (NCT01467973).
Statistical analysis
Descriptive statistics were used to summarize frequency tabulations (n, %) and distributions (mean, standard deviation). All results were summarized overall and by subgroup populations.
Multivariate logistic regression analysis was performed after adjustment for all confounders (age, sex, body mass index, history of HF, diabetes mellitus, coronary artery disease, systolic blood pressure, and heart rate at admission and impaired renal function, defined as estimated glomerular filtration rate (eGFR) mL/min/1.73 m2 using Cockcroft and Gault formula eGFR (mL/min)= ({140-age} × Weight/[0.814 × serum creatinine (SCr) in μmol/L]) × (0.85 if female) and to identify important precipitating risk factors for rehospitalization in patients with AHF across GCC countries. Univariate and covariate-adjusted Cox proportional hazards regression models were used to estimate the association between the presence of precipitating factors and the outcomes of the 90-day and 12-month risk of death. A p < 0.05 (two-tailed) was considered a cutoff value for statistical significance. SPSS 22.0 Statistical package (Chicago, IL, USA) was used for the analysis.
| Results | | |
A total of 5005 patients were enrolled, and the mean age of the cohort was 59.3 ± 14.9 years. Around 50.8% of AHF patients were from GCC nations, and the majority were male (62.5%; P < 0.001). During 3- and 12-month follow-up, a significant 22.1% of the GCC nationalities in 3 months (P < 0.001) and 18.3% of the nonGCC nationalities in 12 months underwent rehospitalization due to AHF. The overall in-hospital mortality was 6.3%. A total of 18% (n = 903) and 21.4% (n = 1075) of the patients were rehospitalized during 3-month and 12-month follow-up. [Table 1] shows baseline characteristics, adjusted for comorbidities, management, and follow-up data of the stratified population. | Table 1: Patient demographics and clinical characteristics in gulf acute heart failure registry cohort (n=5005)
Click here to view |
Prognostic and precipitating factors in the individual regions are summarized in [Table 2] for AHF patients. The three most common precipitating factors of HF were ACS (n = 1365; 27.2%), nonadherence to diet (n = 964; 19.2%) and infection (n = 731; 14.6%). | Table 2: Gulf acute heart failure registry country-specific prognostic and precipitating factors for rehospitalization of heart failure patients (n=5005)
Click here to view |
After adjustment of cofounders (demographic and clinical variables) that precipitate worsening of HF, in the spectrum of Gulf CARE participating countries, multivariate analysis for predictors of increased hospitalization demonstrated that uncontrolled hypertension, ACS, nonadherence to diet, and medications are significant precipitating factors for rehospitalization [Table 3]. For example, patients with uncontrolled hypertension showed 5.28 times and nonadherence to diet (4.20 times) increased the risk of rehospitalization among Kuwait patients. Furthermore, patients with ACS, uncontrolled hypertension, and nonadherence to diet were also more likely to be rehospitalized. | Table 3: Heart failure patient is precipitating factors for rehospitalization across gulf acute heart failure registry cohort
Click here to view |
Among the patients with various precipitating factors, every prognostic determinant (age, gender, diabetes, history of HF, blood pressure, and heart rate at admission) was adjusted and was strictly associated with 3-month and 12-month mortality.
AHF patients precipitated by infection and ACS during hospitalization showed the higher 90-day hazard of mortality (hazard ratio [HR] 1.40, 95% CI 1.10–1.78; P < 0.001 and HR 1.23, 95% confidence interval [CI] 0.99-1.52; P < 0.001). Similarly, AHF precipitated by infection and non-adherence to diet and medications showed a persistently higher risk of 12-month mortality compared with AHF patients without identified precipitants. Moreover, hypertension and AF as a precipitating factor showed a reduced risk of death at 12-month posthospitalization compared with AHF without identified precipitants (HR 0.89, 95% CI 0.61–1.31 and HR 0.91, 95% CI 0.74–1.12), but not a significant association [Figure 1]. | Figure 1: Precipitating factors and risk of death in 3-months and 12-months. HR: Hazard ratio, CI: Confidence interval
Click here to view |
| Discussion | | |
The Gulf CARE enrolled 5005 AHF patients admitted to 47 hospitals across 7 Middle Eastern countries and prospectively followed them for 12 months. This allowed us to assess patient outcomes and contributing factors associated with frequent hospitalization and mortality in these patients.
The main findings are: (i) 21.4% of AHF patients from NYHA classes I and II were rehospitalized during 12-months of follow-up, (ii) ACS (27.2%), nonadherence to diet (19.2%), and infection (14.6%) were most common precipitating factors of HF, (iii) nonadherence to medications, uncontrolled hypertension, and ACS significantly increase the risk of rehospitalization, (iv) there are significant differences between regions in precipitating risk factors for HF patients readmission, and (v) AHF patients precipitated by infection and ACS at readmission have the highest 90-day hazard of mortality, and nonadherence to diet and medications showed a persistently higher risk of 12-month mortality.
Numerous clinical factors can trigger a worsening of AHF, and one or more precipitating factors or comorbidities have been identified in a majority of patients admitted with acute decompensated HF (ADHF).[4],[17],[18],[19],[20] Any of these factors alone or in combination can initiate pathophysiological processes resulting in acute circulatory decompensation leading to hospitalization.[21],[22],[23]
Identifying precipitating factors, relieving symptoms adequately, and following up on patients carefully can improve short- and long-term outcomes and can reduce frequent rehospitalization. AHF has several underlying etiologies, but ACS remained the most frequent precipitating factor in the Gulf CARE cohort, similar to OPTIMIZE-HF, French EFICA, and the recent intercontinental GREAT registry.[4],[22],[23] The intercontinental GREAT registry highlighted that ACS increases the risk of death only transiently during the first week after hospitalization (HR 2.57, 95% CI 2.22–2.99, P < 0.001).[24]
Similarly, uncontrolled blood pressure also identified as an important precipitating factor (>90% of all AHF episodes are associated with normal or elevated blood pressure). There is overwhelming evidence that primary prevention of symptomatic HF strongly depends on blood pressure reduction[4],[18],[19],[25] and systolic blood pressure >140 mmHg acts as a principal determinant of in-hospital morbidity and mortality.[8],[23],[24],[25],[26],[27] A large RCT demonstrated that targeting a significant reduction in systolic blood pressure in those at increased risk of cardiovascular disease is a novel strategy to prevent HF.[28] In our study, we identified that uncontrolled hypertension and nonadherence to medications as precipitants is associated with an increased risk of hospitalization. It is evident from the US study that the proportion of patients treated for hypertension was improved from 59.8% to 74.7%, and the proportion of adequate blood-controlled blood pressure improved from 53.3% to 68.9%.[29] These findings highlight the improvement in blood pressure control is likely to make a significant contribution to the decline in the incidence of hospitalization of HF patients. Furthermore, improved in-hospital and postdischarge systolic blood pressure control as a precipitant of HF admission is associated with better outcomes.[30] However, prognostic factors such as being more symptomatic, having lower systolic blood pressure, worse renal function, and higher troponins at baseline were some of the significant factors for HF hospitalization.[31],[32],[33],[34],[35]
Identifying patients at high risk of developing symptomatic HF and other cardiovascular conditions is an important step to an effective preventive strategy for hospitalization.
Further studies should be designed to test interventions targeting these contributing factors in post-HF hospitalization prospectively. It should be noted that patients with ACS, infection and nonadherence to diet or medication as admission precipitants were at high adjusted risk of 90-day and 12-months postdischarge mortality. Patients identified with these precipitating factors should be counseled during the index hospitalization, and more emphasis should be given at discharge to improve postdischarge outcomes.
Several reviews and meta-analyses demonstrated that physical conditioning and training improve exercise tolerance, quality of life, and rate of hospitalization in patients with stable HF, in NYHA I-III functional class.[36],[37],[38] Of note, a high number of patients in NYHA functional class I-II with stable HF were also readmitted within 12 months of the follow-up period. In general, data collected from clinical studies data rule out exercising in patients with AHF, however early mobilization and a personalized training program following hospitalization can prevent disability progress, and further investigation is required concerning cardiac rehabilitation in reducing rehospitalization among discharged HF patients.
Our study has some limitations. First, like any observational study, the possibility of selection bias could exist. Second, the 47 hospitals that participated may not be representative, and the results cannot be generalized. Finally, underreporting of comorbidities, especially subclinical disease, might have occurred, and this could have led to an overestimation of the impact of these comorbid conditions. We collected the data through a well-designed electronic system to obtain quality and complete data with only a few missing data.
| Conclusion | | |
Precipitating factors such as ACS, infection, nonadherence to diet, and medication were identified as influencing frequent hospitalization and risk of mortality. Hence, early detection, management, and approach monitoring of these prognostic factors in-hospital and postdischarge should be prioritized in optimizing the management of HF in our region.
Acknowledgment
We thank all the Gulf Care co-investigators and data collectors other than the authors listed in this manuscript.
Financial support and sponsorship
Gulf CARE is an investigator-initiated study conducted under the auspices of the GHA and funded by Servier, Paris, France; and-for centers in Saudi Arabia-by the Saudi Heart Association. Dr. Abi Khalil's lab is funded by the Biomedical Research Program (BMRP) at Weill Cornell Medicine Qatar, and partially by the pilot study 15-16, a program funded by Qatar Foundation. Dr. Al-Habib's lab is funded by the Saudi Heart Association and The Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia (Research group number: RG-1436-013). All of the sources mentioned above did not have a role in the study's concept, analysis, and writing of the manuscript.
Conflicts of interest
There are no conflicts of interest.
| References | | |
| 1. | Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: Findings from OPTIMIZE-HF. Arch Intern Med 2008;168:847-54.  |
| 2. | Adams KF Jr., Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149:209-16. |
| 3. | O'Connor CM, Stough WG, Gallup DS, Hasselblad V, Gheorghiade M. Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: Observations from the IMPACT-HF registry. J Card Fail 2005;11:200-5. |
| 4. | Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The global health and economic burden of hospitalizations for heart failure: Lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 2014;63:1123-33. |
| 5. | Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F, et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail 2016;18:613-25. |
| 6. | Al-Shamiri MQ. Heart failure in the Middle East. Curr Cardiol Rev 2013;9:174-8. |
| 7. | AlHabib KF, Elasfar AA, Alfaleh H, Kashour T, Hersi A, AlBackr H, et al. Clinical features, management, and short-and long-term outcomes of patients with acute decompensated heart failure: Phase I results of the HEARTS database. Eur J Heart Fail 2014;16:461-9. |
| 8. | Al Suwaidi J, Asaad N, Al-Qahtani A, Al-Mulla AW, Singh R, Albinali HA. Prevalence and outcome of Middle-eastern Arab and South Asian patients hospitalized with heart failure: Insight from a 20-year registry in a Middle-eastern country (1991-2010). Acute Card Care 2012;14:81-9. |
| 9. | Sulaiman KJ, Panduranga P, Al-Zakwani I, Alsheikh-Ali A, Al-Habib K, Al-Suwaidi J, et al. Rationale, design, methodology and hospital characteristics of the first gulf acute heart failure registry (Gulf CARE). Heart Views 2014;15:6-12. [ PUBMED] [Full text] |
| 10. | Khafaji HA, Sulaiman K, Singh R, AlHabib KF, Asaad N, Alsheikh-Ali A, et al. Clinical characteristics, precipitating factors, management and outcome of patients with prior stroke hospitalised with heart failure: An observational report from the Middle East. BMJ Open 2015;5:e007148. |
| 11. | Sulaiman K, Panduranga P, Al-Zakwani I, Alsheikh-Ali AA, AlHabib KF, Al-Suwaidi J, et al. Clinical characteristics, management, and outcomes of acute heart failure patients: Observations from the Gulf acute heart failure registry (Gulf CARE). Eur J Heart Fail 2015;17:374-84. |
| 12. | Hassan M. Gulf CARE: Heart failure in the Middle East. Glob Cardiol Sci Pract. 2015;2015:34. doi: 10.5339/gcsp.2015.34. |
| 13. | Panduranga P, Al-Zakwani I, Sulaiman K, Al-Habib K, Alsheikh-Ali A, Al-Suwaidi J, et al. Comparison of Indian subcontinent and Middle East acute heart failure patients: Results from the gulf acute heart failure registry. Indian Heart J 2016;68 Suppl 1:S36-44. |
| 14. | Salam AM, Sulaiman K, Al-Zakwani I, Alsheikh-Ali A, Aljaraallah M, Al Faleh H, et al. Coronary artery disease prevalence and outcome in patients hospitalized with acute heart failure: An observational report from seven Middle Eastern countries. Hosp Pract (1995) 2016;44:242-51. |
| 15. | Al-Lawati JA, Sulaiman KJ, Al-Zakwani I, Alsheikh-Ali AA, Panduranga P, Al-Habib KF, et al. Systolic blood pressure on admission and mortality in patients hospitalized with acute heart failure: Observations from the gulf acute heart failure registry. Angiology 2017;68:584-91. |
| 16. | Abi Khalil C, Sulaiman K, Singh R, Jayyousi A, Asaad N, AlHabib KF, et al. BMI is inversely correlated to the risk of mortality in patients with type 2 diabetes hospitalized for acute heart failure: Findings from the Gulf aCute heArt failuRE (Gulf-CARE) registry. Int J Cardiol 2017;241:262-9. |
| 17. | Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, et al. Acute heart failure syndromes: Current state and framework for future research. Circulation 2005;112:3958-68. |
| 18. | Flaherty JD, Bax JJ, De Luca L, Rossi JS, Davidson CJ, Filippatos G, et al. Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. J Am Coll Cardiol 2009;53:254-63. |
| 19. | Fishbein D. Acute decompensated heart failure: Classification, epidemiology and pathophysiology. In: Heart Failure. Vol. 18. London: Springer; 2017. p. 149-70. |
| 20. | Blecker S, Ladapo JA, Doran KM, Goldfeld KS, Katz S. Emergency department visits for heart failure and subsequent hospitalization or observation unit admission. Am Heart J 2014;168:901-8.e1. |
| 21. | Soltani MH, Alemzadeh-Ansari MJ, Taghavi S, Ghadrdoost B, Maleki M, Amin A, et al. Worsening renal function in acute decompensated systolic heart failure; observations from RASHF registry, an Iranian heart failure registry. Int Cardiovasc Res J 2017;11:18-24. |
| 22. | Zannad F, Mebazaa A, Juillière Y, Cohen-Solal A, Guize L, Alla F, et al. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail 2006;8:697-705. |
| 23. | Arrigo M, Gayat E, Parenica J, Ishihara S, Zhang J, Choi DJ, et al. Precipitating factors and 90-day outcome of acute heart failure: A report from the intercontinental GREAT registry. Eur J Heart Fail 2016;19:201-8. |
| 24. | Carey SA, Bass K, Saracino G, East CA, Felius J, Grayburn PA, et al. Probability of accurate heart failure diagnosis and the implications for hospital readmissions. Am J Cardiol 2017;119:1041-6. |
| 25. | Kajimoto K, Sato N, Sakata Y, Takano T; Acute Decompensated Heart Failure Syndromes (ATTEND) Investigators. Relationship between systolic blood pressure and preserved or reduced ejection fraction at admission in patients hospitalized for acute heart failure syndromes. Int J Cardiol 2013;168:4790-5. |
| 26. | Gheorghiade M, Vaduganathan M, Fonarow GC, Bonow RO. Rehospitalization for heart failure: Problems and perspectives. J Am Coll Cardiol 2013;61:391-403. |
| 27. | Bozkurt B, Aguilar D, Deswal A, Dunbar SB, Francis GS, Horwich T, et al. Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: A scientific statement from the American Heart Association. Circulation 2016;134:e535-78. |
| 28. | SPRINT Research Group; Wright JT Jr., Williamson JD, Whelton PK, Snyder JK, Sink KM, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103-16. |
| 29. | Egan BM, Li J, Hutchison FN, Ferdinand KC. Hypertension in the United States, 1999 to 2012: Progress toward healthy people 2020 goals. Circulation 2014;130:1692-9. |
| 30. | Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006;296:2217-26. |
| 31. | Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr., Colvin MM, et al. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: An update of the 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart failure society of America. J Am Coll Cardiol 2016;68:1476-88. |
| 32. | Carubelli V, Cotter G, Davison B, Gishe J, Senger S, Bonadei I, et al. In-hospital worsening heart failure in patients admitted for acute heart failure. Int J Cardiol 2016;225:353-61. |
| 33. | Pandey A, Golwala H, Sheng S, DeVore AD, Hernandez AF, Bhatt DL, et al. Factors associated with and prognostic implications of cardiac troponin elevation in decompensated heart failure with preserved ejection fraction: Findings from the American Heart Association get with the guidelines-heart failure program. JAMA Cardiol 2017;2:136-45. |
| 34. | Cotter G, Davison BA, Milo O, Bourge RC, Cleland JG, Jondeau G, et al. Predictors and associations with outcomes of length of hospital stay in patients with acute heart failure: Results from VERITAS. J Card Fail 2016;22:815-22. |
| 35. | Tung YC, Chou SH, Liu KL, Hsieh IC, Wu LS, Lin CP, et al. Worse prognosis in heart failure patients with 30-day readmission. Acta Cardiol Sin 2016;32:698-707. |
| 36. | Rees K, Taylor RS, Singh S, Coats AJ, Ebrahim S. Exercise based rehabilitation for heart failure. Cochrane Database Syst Rev 2004;3:CD003331. |
| 37. | Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129-200. |
| 38. | Lewinter C, Doherty P, Gale CP, Crouch S, Stirk L, Lewin RJ, et al. Exercise-based cardiac rehabilitation in patients with heart failure: A meta-analysis of randomised controlled trials between 1999 and 2013. Eur J Prev Cardiol 2015;22:1504-12. |
[Figure 1]
[Table 1], [Table 2], [Table 3]
|
